Nanomedicines for the Delivery of Biologics

A special symposium of the Academy of Pharmaceutical Sciences Nanomedicines Focus Group reviewed the current status of the use of nanomedicines for the delivery of biologics drugs. This meeting was particularly timely with the recent approval of the first siRNA-containing product Onpattro™ (patisira...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahlich, John, Desai, Arpan, Greco, Francesca, Hill, Kathryn, Jones, Arwyn T., Mrsny, Randall J., Pasut, Gianfranco, Perrie, Yvonne, Seib, F. Philipp, Seymour, Leonard W., Uchegbu, Ijeoma F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572454/
https://www.ncbi.nlm.nih.gov/pubmed/31058802
http://dx.doi.org/10.3390/pharmaceutics11050210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572454/
https://www.ncbi.nlm.nih.gov/pubmed/31058802
http://dx.doi.org/10.3390/pharmaceutics11050210

Ejemplares similares